Mammography Market Size, Share, and Trends 2025 to 2034

Mammography Market (By Product: Film Screen Systems, Digital Systems, Analog Systems, Biopsy Systems, 3D Systems, Others; By Technology: Breast Tomosynthesis Mammography, CAD Mammography, Digital Mammography; By Modality: Portable, Non-Portable; By End Use: Hospitals, Special Clinics, Diagnosis Centers, Ambulatory Surgical Centers, Educational & Research Institutes) – Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034

Last Updated : 13 Nov 2025  |  Report Code : 1854  |  Category : Healthcare   |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Mammography Market 

5.1. COVID-19 Landscape: Mammography Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Mammography Market, By Product

8.1. Mammography Market, by Product

8.1.1. Film Screen Systems

8.1.1.1. Market Revenue and Forecast

8.1.2. Digital Systems

8.1.2.1. Market Revenue and Forecast

8.1.3. Analog Systems

8.1.3.1. Market Revenue and Forecast

8.1.4. Biopsy Systems

8.1.4.1. Market Revenue and Forecast

8.1.5. 3D Systems

8.1.5.1. Market Revenue and Forecast

8.1.6. Others

8.1.6.1. Market Revenue and Forecast

Chapter 9. Global Mammography Market, By Technology

9.1. Mammography Market, by Technology e

9.1.1. Breast Tomosynthesis Mammography

9.1.1.1. Market Revenue and Forecast

9.1.2. CAD Mammography

9.1.2.1. Market Revenue and Forecast

9.1.3. Digital Mammography

9.1.3.1. Market Revenue and Forecast

Chapter 10. Global Mammography Market, By Modality 

10.1. Mammography Market, by Modality

10.1.1. Portable

10.1.1.1. Market Revenue and Forecast

10.1.2. Non-Portable

10.1.2.1. Market Revenue and Forecast

Chapter 11. Global Mammography Market, By End Use 

11.1. Mammography Market, by End Use

11.1.1. Hospitals

11.1.1.1. Market Revenue and Forecast

11.1.2. Special Clinics

11.1.2.1. Market Revenue and Forecast

11.1.3. Diagnosis Centers

11.1.3.1. Market Revenue and Forecast

11.1.4. Ambulatory Surgical Centers

11.1.4.1. Market Revenue and Forecast

11.1.5. Educational & Research Institutes

11.1.5.1. Market Revenue and Forecast

Chapter 12. Global Mammography Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product

12.1.2. Market Revenue and Forecast, by Technology

12.1.3. Market Revenue and Forecast, by Modality

12.1.4. Market Revenue and Forecast, by End Use

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product

12.1.5.2. Market Revenue and Forecast, by Technology

12.1.5.3. Market Revenue and Forecast, by Modality

12.1.5.4. Market Revenue and Forecast, by End Use

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product

12.1.6.2. Market Revenue and Forecast, by Technology

12.1.6.3. Market Revenue and Forecast, by Modality

12.1.6.4. Market Revenue and Forecast, by End Use

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product

12.2.2. Market Revenue and Forecast, by Technology

12.2.3. Market Revenue and Forecast, by Modality

12.2.4. Market Revenue and Forecast, by End Use

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product

12.2.5.2. Market Revenue and Forecast, by Technology

12.2.5.3. Market Revenue and Forecast, by Modality

12.2.5.4. Market Revenue and Forecast, by End Use

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product

12.2.6.2. Market Revenue and Forecast, by Technology

12.2.6.3. Market Revenue and Forecast, by Modality

12.2.6.4. Market Revenue and Forecast, by End Use

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product

12.2.7.2. Market Revenue and Forecast, by Technology

12.2.7.3. Market Revenue and Forecast, by Modality

12.2.7.4. Market Revenue and Forecast, by End Use

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product

12.2.8.2. Market Revenue and Forecast, by Technology

12.2.8.3. Market Revenue and Forecast, by Modality

12.2.8.4. Market Revenue and Forecast, by End Use

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product

12.3.2. Market Revenue and Forecast, by Technology

12.3.3. Market Revenue and Forecast, by Modality

12.3.4. Market Revenue and Forecast, by End Use

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product

12.3.5.2. Market Revenue and Forecast, by Technology

12.3.5.3. Market Revenue and Forecast, by Modality

12.3.5.4. Market Revenue and Forecast, by End Use

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product

12.3.6.2. Market Revenue and Forecast, by Technology

12.3.6.3. Market Revenue and Forecast, by Modality

12.3.6.4. Market Revenue and Forecast, by End Use

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product

12.3.7.2. Market Revenue and Forecast, by Technology

12.3.7.3. Market Revenue and Forecast, by Modality

12.3.7.4. Market Revenue and Forecast, by End Use

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product

12.3.8.2. Market Revenue and Forecast, by Technology

12.3.8.3. Market Revenue and Forecast, by Modality

12.3.8.4. Market Revenue and Forecast, by End Use

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product

12.4.2. Market Revenue and Forecast, by Technology

12.4.3. Market Revenue and Forecast, by Modality

12.4.4. Market Revenue and Forecast, by End Use

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product

12.4.5.2. Market Revenue and Forecast, by Technology

12.4.5.3. Market Revenue and Forecast, by Modality

12.4.5.4. Market Revenue and Forecast, by End Use

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product

12.4.6.2. Market Revenue and Forecast, by Technology

12.4.6.3. Market Revenue and Forecast, by Modality

12.4.6.4. Market Revenue and Forecast, by End Use

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product

12.4.7.2. Market Revenue and Forecast, by Technology

12.4.7.3. Market Revenue and Forecast, by Modality

12.4.7.4. Market Revenue and Forecast, by End Use

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product

12.4.8.2. Market Revenue and Forecast, by Technology

12.4.8.3. Market Revenue and Forecast, by Modality

12.4.8.4. Market Revenue and Forecast, by End Use

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product

12.5.2. Market Revenue and Forecast, by Technology

12.5.3. Market Revenue and Forecast, by Modality

12.5.4. Market Revenue and Forecast, by End Use

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product

12.5.5.2. Market Revenue and Forecast, by Technology

12.5.5.3. Market Revenue and Forecast, by Modality

12.5.5.4. Market Revenue and Forecast, by End Use

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product

12.5.6.2. Market Revenue and Forecast, by Technology

12.5.6.3. Market Revenue and Forecast, by Modality

12.5.6.4. Market Revenue and Forecast, by End Use

Chapter 13. Company Profiles

13.1. Hologic

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Fujifilm

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Siemens Healthcare

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Phillips Healthcare

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Toshiba Medical Systems

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. GE Healthcare

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Metaltronica

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. I.M.S. Srl

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Koninklijke Philips NV

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Gamma Medica, Inc

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global mammography market size was accounted at USD 2.60 billion in 2025 and it is expected to reach around USD 5.51 billion by 2034.

The global mammography market is poised to grow at a CAGR of 7.80% from 2025 to 2034.

The major players operating in the mammography market are Hologic, Fujifilm, Siemens Healthcare, Phillips Healthcare, Toshiba Medical Systems, GE Healthcare, Metaltronica, I.M.S. Srl, Koninklijke Philips NV, Gamma Medica, Inc., Konica Minolta,usiness Solutions India Private Limited, Carestream Health, BMI Biomedical International SRL, Canon Inc, MetaltronicaSpA, PLANNED OY, GENERAL MEDICAL ITALIA, Villa Systems Medical SpA

Rising revenue for precisely further created Breast disease screening systems is one of the central factors expected to drive the market.

North America region will lead the global mammography market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client